Supply shortage · 04.08.2026
Supply shortage: Praluent 150 mg Injektionslösung im Fertigpen
Affected country: Denmark · Reported period: Early June 2026 – Early August 2026 · Active ingredient: Alirocumab
Notice context
A supply shortage has been recorded for Praluent 150 mg Injektionslösung im Fertigpen in Denmark. The stated reason is “Production problems”. The notice concerns the active ingredient Alirocumab and is not identified as hospital-relevant.
This information describes the reported supply status and is not medical or pharmaceutical treatment advice. Availability, alternatives and further measures must be assessed for each individual case by the responsible pharmaceutical market participants.
Official shortage notice for Denmark. Responsibility and update procedures follow the information supplied by the relevant authority.
Check the official notice list →